Predictive and Prognostic Significance of Patient-Reported Outcomes for Survival and Adverse Events in Daratumumab-Treated Multiple Myeloma

Citation:

Abuhelwa AY, Almansour SA, Basch E, et al. Eur J Haematol. 2025 Jun;114(6):1020-1031. Epub 2025 Mar 14. PMID: 40084510; PMCID: PMC12053969.